G2/M arrest and mitotic slippage induced by fenbendazole in canine melanoma cells

Abstract Background The use of fenbendazole (FBZ) in terminal cancer patients has recently increased, as anthelminthic drugs, such as FBZ and benzimidazole, exhibit anti‐tubulin effects in tumour cells. Objectives The present study evaluated the in vitro anti‐cancer effects of FBZ in five canine mel...

Full description

Bibliographic Details
Main Authors: Sehoon Kim, Shashini Kanchanamala Perera, Seo‐In Choi, Robert B. Rebhun, Kyoung‐won Seo
Format: Article
Language:English
Published: Wiley 2022-05-01
Series:Veterinary Medicine and Science
Subjects:
Online Access:https://doi.org/10.1002/vms3.733
_version_ 1797683423589957632
author Sehoon Kim
Shashini Kanchanamala Perera
Seo‐In Choi
Robert B. Rebhun
Kyoung‐won Seo
author_facet Sehoon Kim
Shashini Kanchanamala Perera
Seo‐In Choi
Robert B. Rebhun
Kyoung‐won Seo
author_sort Sehoon Kim
collection DOAJ
description Abstract Background The use of fenbendazole (FBZ) in terminal cancer patients has recently increased, as anthelminthic drugs, such as FBZ and benzimidazole, exhibit anti‐tubulin effects in tumour cells. Objectives The present study evaluated the in vitro anti‐cancer effects of FBZ in five canine melanoma cell lines originating from the oral cavity (UCDK9M3, UCDK9M4, UCDK9M5, KMeC and LMeC). Methods Five canine melanoma cell lines were treated with FBZ and analysed with cell viability assay, cell cycle analysis, western blot assay and immunofluorescence staining to identify apoptotic effect, cell cycle arrest, microtubule disruption and mitotic slippage. Results Cell viability was reduced in all melanoma cell lines in a dose‐dependent manner after FBZ treatment. Through cell cycle analysis, G2/M arrest and mitotic slippage were identified, which showed a time‐dependent change. All treatment concentrations induced increased cleaved PARP signals in western blot analysis compared to the control groups. Immunofluorescence of cells treated for 24 h revealed defects in microtubule structure, multinucleation or macronucleation. With the exception of UCDK9M3, the melanoma cells showed mitotic slippage and post‐slippage death, indicative of mitotic catastrophe. Conclusions These results indicate that FBZ exhibits anti‐cancer effects in vitro against canine melanoma cells; however, further in vivo studies regarding the clinical applications of FBZ are required.
first_indexed 2024-03-12T00:15:05Z
format Article
id doaj.art-951bc0c7b05d4e67a9e7d6d541eb08a1
institution Directory Open Access Journal
issn 2053-1095
language English
last_indexed 2024-03-12T00:15:05Z
publishDate 2022-05-01
publisher Wiley
record_format Article
series Veterinary Medicine and Science
spelling doaj.art-951bc0c7b05d4e67a9e7d6d541eb08a12023-09-15T15:20:44ZengWileyVeterinary Medicine and Science2053-10952022-05-018396698110.1002/vms3.733G2/M arrest and mitotic slippage induced by fenbendazole in canine melanoma cellsSehoon Kim0Shashini Kanchanamala Perera1Seo‐In Choi2Robert B. Rebhun3Kyoung‐won Seo4Department of Veterinary Internal Medicine, College of Veterinary Medicine Chungnam National University Daejeon KoreaDepartment of Veterinary Internal Medicine, College of Veterinary Medicine Chungnam National University Daejeon KoreaDepartment of Veterinary Internal Medicine, College of Veterinary Medicine Chungnam National University Daejeon KoreaCenter for Companion Animal Health Department of Surgical and Radiological Sciences, School of Veterinary Medicine University of California Davis CaliforniaDepartment of Veterinary Internal Medicine, College of Veterinary Medicine Seoul National University Korea SeoulAbstract Background The use of fenbendazole (FBZ) in terminal cancer patients has recently increased, as anthelminthic drugs, such as FBZ and benzimidazole, exhibit anti‐tubulin effects in tumour cells. Objectives The present study evaluated the in vitro anti‐cancer effects of FBZ in five canine melanoma cell lines originating from the oral cavity (UCDK9M3, UCDK9M4, UCDK9M5, KMeC and LMeC). Methods Five canine melanoma cell lines were treated with FBZ and analysed with cell viability assay, cell cycle analysis, western blot assay and immunofluorescence staining to identify apoptotic effect, cell cycle arrest, microtubule disruption and mitotic slippage. Results Cell viability was reduced in all melanoma cell lines in a dose‐dependent manner after FBZ treatment. Through cell cycle analysis, G2/M arrest and mitotic slippage were identified, which showed a time‐dependent change. All treatment concentrations induced increased cleaved PARP signals in western blot analysis compared to the control groups. Immunofluorescence of cells treated for 24 h revealed defects in microtubule structure, multinucleation or macronucleation. With the exception of UCDK9M3, the melanoma cells showed mitotic slippage and post‐slippage death, indicative of mitotic catastrophe. Conclusions These results indicate that FBZ exhibits anti‐cancer effects in vitro against canine melanoma cells; however, further in vivo studies regarding the clinical applications of FBZ are required.https://doi.org/10.1002/vms3.733anti‐tumour effectapoptosiscanine melanoma cellfenbendazoleG2/M cell cycle arrestmitotic slippage
spellingShingle Sehoon Kim
Shashini Kanchanamala Perera
Seo‐In Choi
Robert B. Rebhun
Kyoung‐won Seo
G2/M arrest and mitotic slippage induced by fenbendazole in canine melanoma cells
Veterinary Medicine and Science
anti‐tumour effect
apoptosis
canine melanoma cell
fenbendazole
G2/M cell cycle arrest
mitotic slippage
title G2/M arrest and mitotic slippage induced by fenbendazole in canine melanoma cells
title_full G2/M arrest and mitotic slippage induced by fenbendazole in canine melanoma cells
title_fullStr G2/M arrest and mitotic slippage induced by fenbendazole in canine melanoma cells
title_full_unstemmed G2/M arrest and mitotic slippage induced by fenbendazole in canine melanoma cells
title_short G2/M arrest and mitotic slippage induced by fenbendazole in canine melanoma cells
title_sort g2 m arrest and mitotic slippage induced by fenbendazole in canine melanoma cells
topic anti‐tumour effect
apoptosis
canine melanoma cell
fenbendazole
G2/M cell cycle arrest
mitotic slippage
url https://doi.org/10.1002/vms3.733
work_keys_str_mv AT sehoonkim g2marrestandmitoticslippageinducedbyfenbendazoleincaninemelanomacells
AT shashinikanchanamalaperera g2marrestandmitoticslippageinducedbyfenbendazoleincaninemelanomacells
AT seoinchoi g2marrestandmitoticslippageinducedbyfenbendazoleincaninemelanomacells
AT robertbrebhun g2marrestandmitoticslippageinducedbyfenbendazoleincaninemelanomacells
AT kyoungwonseo g2marrestandmitoticslippageinducedbyfenbendazoleincaninemelanomacells